Current Views on Hepatitis C Virus Infection
- PMID: 11095838
- DOI: 10.1007/s11908-000-0088-7
Current Views on Hepatitis C Virus Infection
Abstract
Hepatitis C virus infection affects more than 4 million people in the United States and is a leading cause of liver failure necessitating transplantation. Effective combination therapies are now available for subgroups of patients at risk for progression to cirrhosis. The benefits of therapy in immunosuppressed hosts, such as HIV-infected patients and liver transplant recipients, are less well established.
Similar articles
-
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.Clin Liver Dis. 2003 Feb;7(1):261-87. doi: 10.1016/s1089-3261(02)00078-8. Clin Liver Dis. 2003. PMID: 12691470 Review.
-
Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection.PLoS One. 2014 Jul 28;9(7):e103028. doi: 10.1371/journal.pone.0103028. eCollection 2014. PLoS One. 2014. PMID: 25068388 Free PMC article.
-
Hepatitis D: A Review.JAMA. 2023 Dec 26;330(24):2376-2387. doi: 10.1001/jama.2023.23242. JAMA. 2023. PMID: 37943548 Review.
-
An update on hepatitis B, D, and E viruses.Top Antivir Med. 2014 Jan;21(5):157-63. Top Antivir Med. 2014. PMID: 24531556 Free PMC article. Review.
-
Management of hepatitis C virus in the transplant patient.Clin Liver Dis. 2007 May;11(2):355-76. doi: 10.1016/j.cld.2007.04.010. Clin Liver Dis. 2007. PMID: 17606212 Review.
References
LinkOut - more resources
Full Text Sources